Related Experiment Videos
Rapid, psychopharmacologically induced improvement can produce new psychological symptoms
Abstract:
The advent of improved diagnostic criteria, coupled with a refined psychotropic armamentarium, can now produce rapid clinical improvements in clinical psychiatric conditions for which both patients and therapist may be unprepared. The following case report illustrates this problem which will become increasingly important in the practice of psychiatry as further improvements in psychopharmacological therapy occurs.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The relationship between living arrangement and adherence to antiepileptic medications among individuals with developmental disabilities.
Journal of intellectual disability research : JIDR·2014
Longitudinal prescribing patterns for psychoactive medications in community-based individuals with developmental disabilities: utilization of pharmacy records.
Journal of intellectual disability research : JIDR·2004
S-adenosylmethionine blood levels in major depression: changes with drug treatment.
Acta neurologica Scandinavica. Supplementum·1994
Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·1992
Investigation of the Gut Microbiome in Treatment-Resistant Schizophrenia Compared to Healthy Controls: A Cross-Sectional Pilot Study: Étude du microbiome intestinal chez les patients atteints de schizophrénie résistante au traitement par rapport aux témoins sains : étude pilote transversale.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Metformin, but Not Aripiprazole, Was Associated With Attenuation of Weight Gain in Clozapine-Treated Inpatients With Concurrent Disorders: A Repeated Measures Cohort Analysis: La metformine, mais non l'aripiprazole, a été associée à une atténuation du gain de poids chez les patients hospitalisés traités par la clozapine et présentant des troubles concomitants : une analyse de cohorte à mesures répétées.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Pharmacological Management of Opioid Use Disorder: A Systematic Review and Network Meta-Analysis: Prise en charge pharmacologique du trouble de l'usage des opiacés : revue systématique et méta-analyse en réseau.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Adherence and Acceptability of Smartphone- and Wearable-Based Digital Phenotyping in Patients With First-Episode Psychosis: Observance et acceptabilité du phénotypage numérique fondé sur les téléphones intelligents et les objets personnels connectés chez les patients présentant un premier épisode de psychose.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Cannabis Use Interacts With Psychosis Vulnerability in Borderline Personality Disorder: La consommation de cannabis interagit avec la vulnérabilité à la psychose dans le trouble de la personnalité limite.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
A Multivariate Approach to Communication Impoverishment and Cognitive Performance in Treatment-Resistant Schizophrenia: Analyse à plusieurs variables portant sur l'appauvrissement de la communication et la performance cognitive dans les cas de schizophrénie résistante au traitement.
Canadian journal of psychiatry. Revue canadienne de psychiatrie·2026
Considerations for classification of methamphetamine stimulant substance use disorder and potential treatments.
Journal of addictive diseases·2026
Effects of psychotherapy interventions on glycemic control and weight loss in adults with type 2 diabetes mellitus: a systematic review and meta-analysis.
Diabetes research and clinical practice·2026
Transforming community health advocates into peer interventionists: a binational harm reduction model.
Frontiers in public health·2026